(Q79298191)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17063175%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17063175%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

1 reference

S Aslam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17063175%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

T Santha

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17063175%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

A Leone

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17063175%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

C Wilcox

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17063175%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

25 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17063175%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17063175%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17063175%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17063175%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

2109-2115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17063175%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ki.5001983

21 December 2019

exact match

0 references

cites work

Traditional and emerging cardiovascular risk factors in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Plasma protein thiol oxidation and carbonyl formation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Modified low density lipoprotein delivers substrate for ceramide formation and stimulates the sphingomyelin-ceramide pathway in human macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Intracoronary infusion of reduced glutathione improves endothelial vasomotor response to acetylcholine in human coronary circulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Effect of antihypertensive treatment with candesartan or amlodipine on glutathione and its redox status, homocysteine and vitamin concentrations in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

State of the arg: protein methylation at arginine comes of age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Detection of NG,NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Effect of Shear Stress on Asymmetric Dimethylarginine Release From Vascular Endothelial Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Chronic angiotensin II receptor blockade reduces (intra)renal vascular resistance in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021

Protein carbonyl measurement by a sensitive ELISA method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001983

7 January 2021